These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22810541)

  • 1. [The immune activity of cytoflavine in the treatment of the diffuse septic peritonitis].
    Matusevich EA
    Khirurgiia (Mosk); 2012; (5):72-5. PubMed ID: 22810541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic immunocorrection treatment of experimental widespread purulent peritonitis].
    Gostishchev VK; Kosinets VA; Matusevich EA; Adamenko GP
    Eksp Klin Farmakol; 2012; 75(2):42-6. PubMed ID: 22550860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunoregulating action of reamberine and its use in the treatment of duffuse peritonitis].
    Kosinets VA
    Khirurgiia (Mosk); 2013; (7):29-32. PubMed ID: 23887320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic correction of the lipid-transport system in experimental diffuse purulent peritonitis].
    Kosinets VA
    Vestn Khir Im I I Grek; 2012; 171(3):92-6. PubMed ID: 22880442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2012; 75(8):39-43. PubMed ID: 23012995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant protection in surgical correction of inborn heart disease with the use of artificial circulation].
    Bakhareva IuA; Nadiradze ZZ
    Khirurgiia (Mosk); 2011; (5):61-5. PubMed ID: 21666584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning].
    Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A
    Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune system disorders and their correction in critically ill patients with toxic and hypoxic encephalopathy].
    Loladze A; Shilov V; Batotsyrenov B; Vasilyev S; Kuznetsov O
    Georgian Med News; 2012 Feb; (203):17-22. PubMed ID: 22466535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of cytoflavin in the treatment of vertebrobasilar insufficiency].
    Beĭn BN; Dravert NE
    Eksp Klin Farmakol; 2010 Apr; 73(4):8-10. PubMed ID: 20486551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the Cytoflavin on the distal polyneuropathy severity in patients with diabetic foot syndrome with arteries mediacalcinosis].
    Skripko VD; Kovalenko AL; Zaplutanov VA
    Khirurgiia (Mosk); 2017; (8):75-78. PubMed ID: 28805783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correction of protein-lipid composition in liver mitochondria during experimental widespread purulent peritonitis].
    Kosinets VA; Osochuk SS; Iarotskaia NN
    Eksp Klin Farmakol; 2012; 75(3):31-4. PubMed ID: 22679751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The application of combined physiotherapeutic methods for the complex treatment of patients with dyscirculatory encephalopathy].
    Shiman AG; Klocheva EG; Kaiumov SF; Shoferova SD; Zhukova MV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (2):9-12. PubMed ID: 22908466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of cognitive dysfunction in patients operated on thyroid gland].
    Golub IE; Pinskiĭ SB; Sorokina LV; Ivankova EN; Kovalenko AL
    Khirurgiia (Mosk); 2011; (10):74-7. PubMed ID: 22334909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoflavine effect on exudative-destructive manifestations of lung tuberculosis in children and teenagers].
    Volchegorskiĭ IA; Novoselov PN; Denisenko IA
    Eksp Klin Farmakol; 2009; 72(4):20-4. PubMed ID: 19803365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ROLE OF SUBSTRATE ANTIHYPOXANTS IN CORRECTION OF ABNORMALITIES OF MYOELECTRICAL ACTIVITY OF GASTROINTESTINAL TRACT IN VICTIMS WITH SEVERE COMBINED TRAUMA].
    Sa'dulaev DSh; Bagnenko SF; Dubikaitis PA; Dzhusoev IG; Lapitskiy AV
    Vestn Khir Im I I Grek; 2015; 174(6):35-41. PubMed ID: 27066656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
    Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
    Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy of basic clinical presentations of chronic brain ischemia].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):60-2. PubMed ID: 21946144
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions].
    Suslina ZA; Romantsov MG; Kovalenko AL; Klocheva EG; Rumintseva SA; Bagnenko SF; Piradov MA; Semke VIa; Sukhanov DS
    Klin Med (Mosk); 2010; 88(4):61-7. PubMed ID: 20919573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free-radical oxidation in liver during experimental widespread purulent peritonitis].
    Kosinets VA; Iarotskaia NN
    Eksp Klin Farmakol; 2012; 75(10):37-41. PubMed ID: 23240157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.